Clinical study to examine the effectiveness of Juzentaihoto in postoperative recovery for colorectal cancer patients - A research investigating the role of cell-mediated immunity in recovery
- Conditions
- Colorectal Cancer
- Registration Number
- JPRN-UMIN000001235
- Lead Sponsor
- Sapporo Medical University School of Medicine First Department of Surgery
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Not provided
1.Patients who did not have complete resection of their bowels 2.Patients who took Traditional Japanese Medicine within four weeks of their surgery 3.Patients who are unable to take the test medication one week after the surgery 4.Patients with preoperative laboratory values falling within the ranges as described below, and their main organs (bone marrow, heart, lungs, kidneys and liver) show advanced, functional disorders: *WBC<or=4,000/mm3 or 12,000/mm3<or=WBC *Platelets<or=100,000/mm3 *Hemoglobin<or=10g/dl *AST (SGOT serum glutamic-oxaloacetic transaminase) > 2x above upper normal range *ALT (SGPT serum glutamic-pyruvic transaminase) > 2x above upper normal range *Serum total bilirubin>or=2.0mg/dl *BUN<or=25mg/dl *Serum creatinine >or=1.5mg/dl 5.Patients who have serious, postoperative complications including infection, diarrhea (watery stool), tube paralysis, bowel obstruction with pleural effusion, ascites or hydropericardium 6.Patients who have clinically active inflammation or complication 7.Patients who are pregnant or are possibly pregnant 8.Patients who fail to meet the eligibility criteria for the study 9.Patients who are unable to sign a written consent 10. Patients who are determined to be unfit for the study by the physician in charge of the research
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method